Use of epsilon aminocaproic acid in protracted bleeding from polycystic kidneys: a case report.
A case is reported in which protracted and massive bleeding from polycystic kidneys was treated successfully with epsilon aminocaproic acid with no adverse effects. Our experience with this case suggests that a short trial with epsilon aminocaproic acid is a reasonable choice before surgical intervention in patients bleeding from polycystic kidneys.
D000328:Adult; D000614:Aminocaproates / Q000627:therapeutic use*; D015119:Aminocaproic Acid / Q000627:therapeutic use*; D006417:Hematuria / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D008297:Male; D007690:Polycystic Kidney Diseases / Q000150:complications*; D013997:Time Factors
D000614:Aminocaproates; D015119:Aminocaproic Acid